Access cutting-edge head and neck cancer treatment through this clinical trial at a research site in Santa Monica. Study-provided care at no cost to qualified participants.
Access head and neck cancer specialists in Santa Monica at no cost
This study follows strict safety protocols and ethical guidelines
All study-related head and neck cancer treatment provided free
This seamless phase 2/3 randomized controlled study will evaluate the efficacy and safety of the hexavalent OX40 agonist antibody INBRX-106 combined with the anti-PD-1 antibody pembrolizumab versus pembrolizumab (+ placebo in phase 3) as first-line treatment for patients with locally advanced recurrent or metastatic head and neck squamous cell carcinoma (R/M HSNSCC) incurable by local therapies, expressing PD-L1 with a combined proportion score (CPS) ≥20.
Sponsor: Inhibrx Biosciences, Inc
Check if you qualify for this head and neck cancer clinical trial in Santa Monica, CA
If you're searching for head and neck cancer treatment options in Santa Monica, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Santa Monica research site is actively enrolling participants for this clinical trial. You'll receive care from experienced head and neck cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.